Studies of vascular remodeling in pulmonary arterial hypertension (PAH), whichis characterized by endothelial dysfunction with release of vasoactive mediators,growth factors, and cytokines [61], show that GDF-15 is increased in PAH lungs,predominantly located in vascular ECs [52]. Here, GDF15 is linked to pulmonary arterial hypertension.